Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast
- PMID: 752852
- DOI: 10.1007/978-3-642-81332-0_17
Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast
Abstract
Following surgery and regional radiotherapy for operable carcinoma of the breast in premenopausal women, ovarian irradiation (2000 rad in five daily fractions) plus prednisone (7.5 mg per day) results in delayed recurrence and prolonged survival.